0 items USD 0.00Search
Your search for "qyresearch united states renal cell carcinoma drug industry 2016 market research report" gave back 819845 results.
The global Kidney Cancer and Renal Cell Carcinoma (RCC) Drugs market size was valued at US$ 4996.3 million in 2023. With growing demand in downstream...
Catalog:
LPI
March 2024
Price: USD 3,660.00
Kidney cancer/ renal cell carcinoma (RCC) is among ten most commonly observed cancer these days. It is sixth common cancer observed in men and it is...
Catalog:
MRRPB5
January 2024
Price: USD 2,900.00
Renal cell carcinoma (RCC) is increasing in incidence and one third of newly diagnosed cases already are metastatic. The metastatic spread of solid...
Catalog:
MRRPB5
February 2024
Price: USD 2,900.00
The global Renal Cell Cacinoma Drugs market is projected to grow from US$ million in 2023 to US$ million by 2029, at a Compound Annual Growth Rate (...
Catalog:
MRRPB5
August 2023
Price: USD 4,900.00
Renal cell carcinoma (RCC) is increasing in incidence and one third of newly diagnosed cases already are metastatic. The metastatic spread of solid...
Catalog:
MRRPB5
May 2023
Price: USD 2,900.00
Renal cell carcinoma (RCC) is increasing in incidence and one third of newly diagnosed cases already are metastatic. The metastatic spread of solid...
Catalog:
MRRPB5
June 2023
Price: USD 4,900.00
Kidney cancer, also known as renal cancer, is a type of cancer that starts in the cells in the kidney. The two most common types of kidney cancer are...
Catalog:
MRRPB5
March 2024
Price: USD 2,900.00
Neoantigen therapy is mainly through high-throughput gene sequencing and data analysis to discover individualized numerous somatic mutations in the...
Catalog:
MRRPB5
June 2023
Price: USD 2,900.00
The global Advanced Renal Cell Carcinoma Treatment market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the...
Catalog:
GIR
May 2023
Price: USD 4,480.00
The global Advanced Renal Cell Carcinoma Treatment market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected...
Catalog:
LPI
April 2023
Price: USD 3,660.00
The global Advanced Renal Cell Carcinoma Treatment market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million...
Catalog:
GIR
May 2023
Price: USD 3,480.00
Market Analysis and Insights: Global Renal Cell Carcinoma Clinical Trial Pipeline Market The global Renal Cell Carcinoma Clinical Trial Pipeline...
Catalog:
MRRPB5
August 2023
Price: USD 4,900.00
Highlights The global Renal Cell Carcinoma Clinical Trial Pipeline market was valued at US$ million in 2022 and is anticipated to reach US$ million...
Catalog:
MRRPB5
May 2023
Price: USD 2,900.00
The global Advanced Renal Cell Carcinoma Treatment market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029,...
Catalog:
MRRPB5
April 2023
Price: USD 2,900.00
Cabozantinib, sold under the brand-name Cabometyx and Cometriq, is a medication used to treat medullary thyroid cancer and a second line treatment...
Catalog:
MRRPB5
November 2023
Price: USD 2,900.00
